Clover Health stock gains after Q2 2026 beat and strong year-to-date rally

Published on 09/03/2026 at 09:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Clover Health stock trades near a 52-week high after Q2 2026 results beat expectations and year-to-date returns far outpace the S&P 500, keeping the Medicare Advantage player in focus for growth-oriented investors.

CLOV, US18914F1030, Illustration mit AI erstellt.

Clover Health Investments Corp. (ISIN US18914F1030) stock is trading close to a 52-week high around USD 4.15 after the company reported Q2 2026 revenue of USD 743.17 million and earnings per share of USD 0.05, topping market estimates in early August 2026 according to MarketBeat data as cited by ad-hoc-news.de on September 2, 2026.

Q2 2026 figures beat expectations

According to an overview of Clover Health covered by MarketBeat and summarized by ad-hoc-news.de on September 2, 2026, Q2 2026 revenue reached USD 743.17 million, which represents a clear increase against historical 2025 quarterly levels and underpins the companys growth in its Medicare Advantage business.

The same report notes that Clover Health posted Q2 2026 earnings per share of USD 0.05, a positive result compared with negative earnings in several earlier quarters, and that both revenue and EPS were above the consensus estimates compiled by analysts, providing a fundamental catalyst for the recent share price strength.

Stock near 52-week high and strong year-to-date performance

Market data compiled by ad-hoc-news.de on September 2, 2026 shows Clover Health stock trading around USD 4.15, close to its 52-week high, after gaining about 3.5% in the latest completed trading session, while an additional forecast from StockInvest.us on September 2, 2026 describes a move from USD 4.15 to USD 4.30 on September 1, 2026, confirming the recent upward trend.

Year-to-date performance numbers from a Yahoo Finance return overview as of September 1, 2026 indicate that Clover Health shares have risen 82.98% in 2026 compared with the benchmark S&P 500 index, highlighting how the stock has significantly outperformed the broader market over the current year.

Go deeper

More on the CLOV stock and fundamentals

Investors can find further background on Clover Health stock and detailed financial figures, including recent quarterly results and guidance, through the topic overview and the companys investor relations site.

All CLOV stock news on ad-hoc-news.de Investor Relations

Business focused on Medicare Advantage technology

Clover Health operates as a technology driven health insurer focused on Medicare Advantage plans in the United States, using its Clover Assistant platform to support physicians with data driven insights and aiming to improve care quality and cost efficiency for its members.

Clover Health stock price context

As of the most recent completed trading day referenced on September 2, 2026, Clover Health stock closed around USD 4.15 on the Nasdaq, with a market capitalization that reflects the strong year-to-date price increase and positions the shares close to their 52-week high range.